On July 25, 2023, USANA HEALTH SCIENCES ($NYSE:USNA) reported their earnings results for the second quarter of FY2023 ending June 30, 2023, with total revenues of USD 238.2 million, a drop of 9.9% compared to the same quarter in the previous fiscal year. Net income also decreased, coming in at USD 17.3 million, a decline of 9.8% year over year.
Analysis – USNA Stock Fair Value Calculator
GoodWhale has conducted an in-depth analysis of USANA HEALTH SCIENCES’s financials and determined that the fair value of the company’s stock is around $91.2. This figure was calculated using our proprietary Valuation Line model, which takes into account both fundamental and technical factors. Currently, USANA HEALTH SCIENCES’s stock is trading at $63.4, meaning it is undervalued by 30.5%. This presents a great buying opportunity for investors, who could potentially realize significant returns by investing in the company at its current, discounted price. More…
Risk Rating Analysis
Star Chart Analysis
About the Company
Ownership (Institutional/ Fund Holdings)
Below shows the total revenue, net income and net margin for USNA. More…
Income Statement Reports (Yearly/ Quarterly/ LTM)
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for USNA. More…
Cash Flow Statement (Yearly/ Quarterly/ LTM)
Cash Flow Supplement
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for USNA. More…
Balance Sheet (Yearly/ Quarterly)
Balance Sheet Supplement
||Book Value Per Share
Key Ratios Snapshot
Some of the financial key ratios for USNA are shown below. More…
Income Statement Ratios
Balance Sheet Ratios
Cash Flow Ratios
Other Supplementary Items
|3Y Rev Growth
||3Y Operating Profit Growth
Founded in 1992, Usana has a long history of providing high quality supplements to its customers.
However, it faces stiff competition from other well-established companies such as Natures Sunshine Products Inc, Naturhouse Health SA, and Empowered Products Inc. These companies all offer similar products and services, but each has its own unique selling points. Ultimately, it is up to the consumer to decide which company offers the best value for their needs.
– Natures Sunshine Products Inc ($NASDAQ:NATR)
Nature’s Sunshine Products Inc is a leading manufacturer and direct seller of nutritional and personal care products. The company has a market cap of 163.6M as of 2022 and a return on equity of 12.0%. Nature’s Sunshine Products Inc manufactures and sells a wide range of products including vitamins, minerals, herbs, and other supplements. The company also offers a variety of personal care products such as skin care, hair care, and cosmetics. Nature’s Sunshine Products Inc is committed to providing quality products and services to its customers.
– Naturhouse Health SA ($LTS:0R9G)
Naturhouse Health SA is a company that provides health and nutrition services. It has a market cap of 95.32M as of 2022 and a return on equity of 29.55%. The company has a network of over 1,700 stores in Europe, Latin America, and China. It offers a range of products and services including weight loss, weight management, and nutrition counseling.
– Empowered Products Inc ($OTCPK:EMPO)
Empowered Products Inc is a publicly traded company that manufactures and sells sexual wellness products. The company has a market capitalization of $941.83 million and a return on equity of -23.8%. Empowered Products Inc’s products are sold online and through retail stores in the United States and internationally. The company’s products include vibrators, lubricants, and other sexual wellness products. Empowered Products Inc is headquartered in Austin, Texas.
USANA Health Sciences reported second quarter results for fiscal year 2023, with total revenue of $238.2 million, a 9.9% decrease compared to the same period last year. Net income was $17.3 million, down 9.8% from the prior year. Investors should consider these numbers and evaluate the company’s potential for future growth. Factors to consider include current economic conditions, competitive environment, marketing strategy, and expected changes in demand for the company’s products and services.
Additionally, investors should analyze the company’s financial statements and assess its ability to meet financial obligations. Overall, USANA Health Sciences’ results paint a mixed picture, and investors should conduct thorough due diligence before investing in the company.